BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25406187)

  • 1. Notch1 mutations are drivers of oral tumorigenesis.
    Izumchenko E; Sun K; Jones S; Brait M; Agrawal N; Koch W; McCord CL; Riley DR; Angiuoli SV; Velculescu VE; Jiang WW; Sidransky D
    Cancer Prev Res (Phila); 2015 Apr; 8(4):277-286. PubMed ID: 25406187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH mutations: multiple faces in human malignancies.
    Mao L
    Cancer Prev Res (Phila); 2015 Apr; 8(4):259-61. PubMed ID: 25712049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel target for oral cancer chemoprevention? Notch quite, yet….
    William WN; El-Naggar AK
    Cancer Prev Res (Phila); 2015 Apr; 8(4):262-5. PubMed ID: 25712052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
    Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma.
    Song X; Xia R; Li J; Long Z; Ren H; Chen W; Mao L
    Clin Cancer Res; 2014 Feb; 20(3):701-10. PubMed ID: 24277457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
    Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
    Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma.
    Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH
    Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
    Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
    PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C; Schlechte H; Bethke G; Reichart PA
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
    Fu J; Su Y; Liu Y; Zhang XY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
    Zheng Y; Song A; Wang C; Zhang W; Liang D; Ding X; Li G; Zhang H; Zhang W; Du Y; Zhou J; Wu H; Wu Y; Song X
    Cell Death Dis; 2020 Aug; 11(8):615. PubMed ID: 32792479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
    Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
    Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations in NOTCH1 ligand-binding regions in Japanese oral squamous cell carcinoma.
    Aoyama K; Ota Y; Kajiwara K; Hirayama N; Kimura M
    Biochem Biophys Res Commun; 2014 Oct; 452(4):980-5. PubMed ID: 25234595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma.
    Lv L; Wang Q; Yang Y; Ji H
    Mol Med Rep; 2019 Jan; 19(1):693-702. PubMed ID: 30387817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.